Core fucosylation and α2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia

Glycobiology

Volumn 21, Issue 2, 2011, Pages 195-205

  Saldova, Radka ^a   Fan, Yue ^a,b   Fitzpatrick, John M ^b,c   Watson, R William G ^a,b   Rudd, Pauline M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

BPH; N linked glycans; Perineural invasion; Prostate cancer; Serum biomarkers

Indexed keywords

FUCOSE; GLYCAN; PROSTATE SPECIFIC ANTIGEN; SIALIC ACID; DIAGNOSTIC AGENT; GLYCOSIDASE; POLYSACCHARIDE; SIALIC ACID DERIVATIVE;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FUCOSYLATION; GLEASON SCORE; HUMAN; HUMAN CELL; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUANTITATIVE ANALYSIS; SIALYLATION; VALIDATION STUDY; BLOOD; CARBOHYDRATE ANALYSIS; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROSTATE; PROSTATE TUMOR; SERUM;

CARBOHYDRATE SEQUENCE; DIAGNOSIS, DIFFERENTIAL; FUCOSE; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SERUM; SIALIC ACIDS;

EID: 79951985619     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq147     Document Type: Article

References (27)

1. Akaike H. 1987. Factor analysis and AIC. Psychometrika. 52:317-332.
2. Arnold JN, Saldova R, Hamid UM, Rudd PM. 2008. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics. 8:3284-3293.
3. Ayala GE, Dai H, Ittmann M, Li R, Powell M, Frolov A, Wheeler TM, Thompson TC, Rowley D. 2004. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 64:6082-6090. (Pubitemid 39129408)
4. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB. 1995. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem. 230:229-238.
5. de la Taille A, Katz A, Bagiella E, Olsson CA, O'Toole KM, Rubin MA. 1999. Perineural invasion on prostate needle biopsy: An independent predictor of final pathologic stage. Urology. 54:1039-1043.
6. Fan Y, Murphy TB, Watson RW. 2009. digeR: A graphical user interface R package for analyzing 2D-DIGE data. Bioinformatics. 25:3033-3034.
7. Fanning DM, Kay E, Fan Y, Fitzpatrick JM, Watson RW. 2010. Prostate cancer grading: The effect of stratification of needle biopsy Gleason score 4 + 3 as high or intermediate grade. BJU Int. 105:631-635.
8. Ferlay J, Parkin DM, Steliarova-Foucher E. 2010. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 46:765-781.
9. Heidenreich A, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, Schmid H-P, van der Kwast TH, Wiegel T, Zattoni F. 2010. European Association of Urology: ARNHEM, The Netherlands: European Association of Urology: Guidelines: Online Guidelines: (2010) English. Available from: http://www.uroweb.org/ guidelines/online-guidelines/Accessed July 2010.
10. Holmes EH, Ostrander GK, Hakomori S. 1986. Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol Chem. 261:3737-3743.
11. Ito Y, Miyauchi A, Yoshida H, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, et al. 2003. Expression of alpha1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: Its linkage to biological aggressiveness and anaplastic transformation. Cancer Lett. 200:167-172. (Pubitemid 38366098)
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics, 2009. CA Cancer J Clin. 59:225-249.
13. Knezevic A, Gornik O, Polasek O, Pucic M, Redzic I, Novokmet M, Rudd PM, Wright AF, Campbell H, Rudan I, et al. 2010. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma Nglycans. Glycobiology. 20:959-969.
14. Knezevic A, Polasek O, Gornik O, Rudan I, Campbell H, Hayward C, Wright A, Kolcic I, O'Donoghue N, Bones J, et al. 2009. Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res. 8:694-701.
15. Kyselova Z, Mechref Y, Kang P, Goetz JA, Dobrolecki LE, Sledge GW, Schnaper L, Hickey RJ, Malkas LH, Novotny MV. 2008. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem. 54:1166-1175. (Pubitemid 352009693)
16. Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, Partin AW. 2007. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology. 69:1095-1101. (Pubitemid 46891611)
17. Matsumoto K, Yokote H, Arao T, Maegawa M, Tanaka K, Fujita Y, Shimizu C, Hanafusa T, Fujiwara Y, Nishio K. 2008. N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor. Cancer Sci. 99:1611-1617.
18. Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, Kitada T, Honke K, Suzuki K, Yoshihara H, Yoshikawa K, et al. 2003. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res. 63:6282-6289. (Pubitemid 37255175)
19. Nogueira L, Corradi R, Eastham JA. 2010. Other biomarkers for detecting prostate cancer. BJU Int. 105:166-169.
20. Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M. 2004. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology. 14:671-679. (Pubitemid 39161974)
21. Osumi D, Takahashi M, Miyoshi E, Yokoe S, Lee SH, Noda K, Nakamori S, Gu J, Ikeda Y, Kuroki Y, et al. 2009. Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci. 100:888-895.
22. Peracaula R, Barrabes S, Sarrats A, Rudd PM, de Llorens R. 2008. Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers. 25: 207-218.
23. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, Abrahams JL, Kim YG, Henry GW, Shadick NA, Weinblatt ME, et al. 2008.HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 376:1-12.
24. Royle L, Radcliffe CM, Dwek RA, Rudd PM. 2006. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol. 347:125-143.
25. Sarrats A, Saldova R, Comet J, O'Donoghue N, de Llorens R, Rudd PM, Peracaula R. 2010. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. OMICS. 14:465-474.
26. Tabares G, Radcliffe CM, Barrabes S, Ramirez M, Aleixandre RN, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R. 2006. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology. 16:132-145. (Pubitemid 43125969)
27. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA. 1989. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol. 142:763-768. (Pubitemid 19226718)